BVS vs SIBN: stock comparison and AI forecast
Bioventus Inc. (BVS) and Si-Bone, Inc. (SIBN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
BVS Bioventus Inc.
- Market Cap
- $898M
- P/E Ratio
- 36.5x
- Size
- small-cap
- AI Forecast
SIBN Si-Bone, Inc.
- Price
- $20.22 +51.5% · 6M
- Market Cap
- $906M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- BVS and SIBN have similar market capitalizations ($898M and $906M).
- BVS carries 1.59 times debt per unit of equity, against 0.36 times for SIBN.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | BVS | SIBN |
|---|---|---|
| Market Cap | $898M | $906M |
| P/E Ratio | 36.53x | – |
| P/B Ratio | 3.73x | 4.97x |
| EPS | $0.36 | $-0.39 |
| Book Value/Share | $3.52 | $4.07 |
| Revenue/Share | $8.57 | $4.77 |
| FCF/Share | $1.24 | $-0.10 |
Profitability & Margins
| Metric | BVS | SIBN |
|---|---|---|
| ROE | – | -8.0% |
| ROA | – | -5.9% |
| ROIC | 11.0% | -7.9% |
| Gross Margin | 68.7% | 79.5% |
| Operating Margin | 9.7% | -8.3% |
| Net Margin | – | -6.8% |
| EBT Margin | 6.8% | -6.7% |
| Tax Rate | -60.3% | 0.0% |
Financial Health
| Metric | BVS | SIBN |
|---|---|---|
| Current Ratio | 1.68x | 9.15x |
| Quick Ratio | 1.16x | 7.55x |
| D/E Ratio | 1.59x | 0.36x |
| Financial Leverage | 2.80x | 1.36x |
| Interest Coverage | – | -1.0x |
| Working Capital | $108M | $196M |
Cash Flow
| Metric | BVS | SIBN |
|---|---|---|
| Operating Cash Flow | $87M | $2M |
| Free Cash Flow | $85M | -$4M |
| Capital Spending | -$2M | -$7M |
| OCF Growth YoY | 56.1% | – |
| FCF Growth YoY | 58.9% | – |
| FCF/Sales | 14.5% | -2.0% |
| CapEx/Sales | 0.4% | 3.2% |
Operational Efficiency
| Metric | BVS | SIBN |
|---|---|---|
| Asset Turnover | 0.87x | 0.86x |
| Receivables Turnover | 4.2x | 6.8x |
| Inventory Turnover | 2.2x | 1.1x |
| Fixed Assets Turnover | 60.3x | 9.8x |
| Days Sales Outstanding | 86 days | 53 days |
| Days Inventory | 165 days | 320 days |
| Payables Period | 51 days | 71 days |
| Cash Conversion Cycle | 200 days | 302 days |
Income Statement
| Metric | BVS | SIBN |
|---|---|---|
| Total Revenue | $586M | $214M |
| Operating Income | $57M | -$18M |
| Net Income | – | -$15M |
| R&D Expense | $12M | $18M |
| SG&A Expense | $327M | $217M |
| Cost of Goods Sold | $183M | $44M |
Dividend & Shareholder Information
| Metric | BVS | SIBN |
|---|---|---|
| Shares Outstanding | 68M | 45M |
BVS vs SIBN: stock comparison and AI forecast
Which is bigger, BVS or SIBN?
BVS and SIBN have similar market capitalizations ($898M and $906M).
Which one does Intratio's AI model rank higher, BVS or SIBN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.